Citigroup Inc Axonics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 647,152 shares of AXNX stock, worth $45.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

647,152

Previous 600,311 7.8%

Holding current value

$45.9 Million

Previous $40.4 Million 11.72%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$67.3 - $69.67 $3.15 Million - $3.26 Million	46,841 Added 7.8%	647,152 $45.1 Million
Q2 2024 Aug 12, 2024	SELL	$66.47 - $69.65 $18.3 Million - $19.1 Million	-274,933 Reduced 31.41%	600,311 $40.4 Million
Q1 2024 May 10, 2024	BUY	$56.67 - $69.36 $49.2 Million - $60.2 Million	868,095 Added 12142.89%	875,244 $60.4 Million
Q4 2023 Feb 09, 2024	BUY	$49.38 - $63.75 $331,142 - $427,507	6,706 Added 1513.77%	7,149 $444,000
Q3 2023 Nov 09, 2023	SELL	$48.64 - $62.51 $847,843 - $1.09 Million	-17,431 Reduced 97.52%	443 $24,000
Q2 2023 Aug 10, 2023	BUY	$47.99 - $60.21 $750,083 - $941,082	15,630 Added 696.52%	17,874 $902,000
Q1 2023 May 11, 2023	SELL	$52.6 - $67.34 $153,539 - $196,565	-2,919 Reduced 56.54%	2,244 $122,000
Q4 2022 Feb 09, 2023	BUY	$59.56 - $76.6 $177,727 - $228,574	2,984 Added 136.94%	5,163 $322,000
Q3 2022 Nov 10, 2022	SELL	$57.96 - $78.12 $128,903 - $173,738	-2,224 Reduced 50.51%	2,179 $153,000
Q2 2022 Aug 10, 2022	BUY	$39.5 - $64.42 $62,963 - $102,685	1,594 Added 56.75%	4,403 $249,000
Q1 2022 May 12, 2022	SELL	$43.74 - $62.76 $1.29 Million - $1.86 Million	-29,580 Reduced 91.33%	2,809 $175,000
Q4 2021 Feb 10, 2022	BUY	$50.01 - $73.35 $1.33 Million - $1.95 Million	26,546 Added 454.32%	32,389 $1.81 Million
Q3 2021 Nov 10, 2021	BUY	$59.21 - $78.66 $345,964 - $459,610	5,843 New	5,843 $380,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account